Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Argentina Lithium (V.LIT) Announces US$90 Million Investment by Stellantis (click to learn more)
ApartmentLove (C.APLV) Integrates OwnerDirect.com with Google to Display Vacation Rental Listings Worldwide (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aequus Pharmaceuticals Inc
V.AQS
Alternate Symbol(s):
AQSZF
Healthcare
Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing, advancing, and promoting differentiated products. The Company is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision...
. Evolve Intensive Gel and Evolve Daily Intensive contains lubricating eye drops intended for use in the relief of discomfort that arises from dry eye sensations, including dryness, soreness, feelings of grit, and irritation. Zimed PF is a preservative-free multi-dose Bimatoprost for glaucoma patients in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. It plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:AQS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(474)
•••
JohnTool321
X
Comment by
JohnTool321
on Oct 16, 2022 8:16am
RE:RE:Volume
(9875)
•••
Lisagerrard17
X
Comment by
Lisagerrard17
on May 30, 2022 11:58am
RE:RE:New Seeking Alpha report
Eminent Acquires Gilbert South Property in Nevada
posted Sep 28, 2023 9:00am by
Eminent Gold Corp
-
|
"The Gilbert South Property represents an exceptional opportunity to explore a well-known historic gold district and having ownership of it puts the company in a much better position to advance the project on its own timeline. We consider this to be one of the best epithermal prospects in the Walker Lane district in Nevada." - Paul Sun, CEO ...read more
(9675)
•••
Larrymartin77
X
Comment by
Larrymartin77
on May 28, 2022 5:15pm
RE:Volume
(5)
•••
WsrThanWenYungr
X
Comment by
WsrThanWenYungr
on Feb 17, 2022 11:48am
RE:RE:New Seeking Alpha report
Only that report is just about a year old now.
(35)
•••
BlacknBulls
X
Comment by
BlacknBulls
on Feb 05, 2022 12:40am
RE:New Seeking Alpha report
I saw the report also
(0)
•••
stockwatch99
X
Post by
stockwatch99
on Apr 07, 2021 4:45pm
New Seeking Alpha report
New report available on Seeking Alpha: https://seekingalpha.com/article/4417929-aequus-pharmaceuticals-new-products-to-accelerate-growth-in-2021 Aequus Pharmaceuticals will be a top stock for this
...more
(10)
•••
baccanal
X
Post by
baccanal
on Mar 03, 2021 8:04am
Warrants to be exercised
Those 14M accelerated warrants ! .12 are going to put some pressure on the share price for the next month
(8)
•••
Launch64
X
Post by
Launch64
on Mar 02, 2021 9:42am
Volume
7.2 million Starting to come from out of the shadows!
(1)
•••
IBN2016
X
Post by
IBN2016
on Oct 19, 2020 11:53am
More news...
And more to come...
(4)
•••
alfhope
X
Post by
alfhope
on Oct 16, 2020 10:19am
news
Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada
(1)
•••
IBN2016
X
Post by
IBN2016
on Oct 07, 2020 2:34pm
What's coming...
Within the next few weeks, expect news on: Status on renewal or modifications of Tacrolimus deal with Sandoz... Approval of Evolve new line of products... Following approval, Status as to the path
...more
(0)
•••
stockwatch99
X
Comment by
stockwatch99
on Sep 23, 2020 8:23am
RE:Have A Few Sheckles Here
Yes they are. Most people don't realize the potential of this company. Look at the market cap and the potential. I've seen other stocks with this potential having a >5x higher market cap at
...more
(315)
•••
LastoftheFranks
X
Post by
LastoftheFranks
on Sep 22, 2020 11:53pm
Have A Few Sheckles Here
Seems Like they're driving towards positive cashflow with the Evolve eye drops.
(6)
•••
molee26
X
Post by
molee26
on Jul 22, 2020 12:14pm
This Dog needs to hunt ! ! !
Stay safe >> M
(4)
•••
alfhope
X
Post by
alfhope
on Apr 21, 2020 12:05pm
news
Aequus Announces Positive Update on Dry Eye Product Launch Plans
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Copper Exploration Company is on the Edge of a Big Discovery
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle
Energy Co. Announces Low Dilutive Development Capital Raise